Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newborn screening: new developments, new dilemmas.

N J Kerruish1, S P Robertson

  • 1Department of Paediatrics and Child Health, Dunedin School of Medicine, University of Otago, PO Box 913, Dunedin, New Zealand. nikki.kerruish@stonebow.otago.ac.nz

Journal of Medical Ethics
|July 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinctive Brain Malformations in Zhu-Tokita-Takenouchi-Kim Syndrome.

AJNR. American journal of neuroradiology·2022
Same author

End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer.

Prostate cancer and prostatic diseases·2017
Same author

A novel role for the DNA repair gene Rad51 in Netrin-1 signalling.

Scientific reports·2017
Same author

Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder.

Molecular psychiatry·2014
Same author

Nager syndrome: confirmation of SF3B4 haploinsufficiency as the major cause.

Clinical genetics·2013
Same author

Osteopathia striata congenita with cranial sclerosis and intellectual disability due to contiguous gene deletions involving the WTX locus.

Clinical genetics·2012
Same journal

Assisted dying and autonomy as an end in itself: a response to Donaldson.

Journal of medical ethics·2026
Same journal

Ethics briefing.

Journal of medical ethics·2026
Same journal

Medical ethics and categorisation.

Journal of medical ethics·2026
Same journal

Suspension or prioritisation? Exploring the ethics of age-based rationing in adult ADHD services.

Journal of medical ethics·2026
Same journal

Ethics of not knowing who we are talking to in qualitative research.

Journal of medical ethics·2026
Same journal

Suicide is not a public health issue and perhaps very few things should be.

Journal of medical ethics·2026
See all related articles

Newborn screening expands with new technology, but evidence for complex genetic disorder screening is debated. Such screening must be evaluated separately from standard newborn testing programs.

Area of Science:

  • Medical genetics
  • Public health policy
  • Pediatric medicine

Background:

  • Technological advancements are driving the expansion of newborn screening programs.
  • Current newborn screening is justified by clear benefits of early detection and treatment for specific conditions.
  • Expanding screening scope presents challenges to existing program perceptions and justifications.

Purpose of the Study:

  • To evaluate the evidence supporting expanded newborn screening, particularly for genetic susceptibility to complex disorders.
  • To differentiate between standard newborn screening and proposed expanded screening approaches.
  • To advocate for a separate consideration of genetic susceptibility screening due to its distinct nature.

Main Methods:

  • Literature review and critical analysis of existing evidence for newborn screening benefits.
Keywords:
Genetics and ReproductionHealth Care and Public Health

Related Experiment Videos

  • Comparative analysis of standard screening protocols versus proposed expanded genetic screening.
  • Ethical and policy considerations regarding the scope and justification of newborn screening.

    • Main Results:

    • Standard newborn screening for specific conditions is well-supported by evidence of reduced morbidity and mortality.
    • Evidence for the unequivocal benefit of screening for genetic susceptibility to complex disorders is less established.
    • The nature and implications of screening for complex genetic predispositions differ significantly from single-gene or metabolic disorder screening.

    Conclusions:

    • While expanded newborn screening holds potential for child health, not all proposals have equivalent evidence of benefit.
    • Screening for genetic susceptibility to complex disorders requires a distinct evaluation framework.
    • Careful consideration and separate assessment are needed for proposals extending newborn screening beyond conventional targets.